The cutting-edge technology used in COVID-19 shots may lead to new treatments for other diseases. But some conservatives are ...
Christopher Ridley, a spokesperson for Moderna, said the state legislative efforts are largely a product of ...
Moderna has gotten torched over the last six months - since September 2024, its stock price has dropped 51.2% to $33.99 per ...
Messenger RNA can travel between different types of stem cells through tunnel-like structures, as revealed by a new study. By studying interactions between mouse and human stem cells, they discovered ...
Fintel reports that on March 13, 2025, Citigroup initiated coverage of Moderna (NasdaqGS:MRNA) with a Neutral recommendation. Analyst Price Forecast Suggests 62.09% Upside As of March 4, 2025, the ...
A bill banning gene-based vaccines, like some forms of the COVID-19 vaccine, received approval from a Senate subcommittee ...
Daiichi Sankyo is stepping up its interest in RNA therapies, teaming with Nosis Biosciences to design drug candidates capable ...